Jul. 23 at 7:23 PM
$HCAT: A behemoth in the making.
Their new ignite platform and push into AI paired with billions of datapoints makes this an attractive investment at these prices.
With revenues returning to double-digit growth in 2025 rising to
$335MM (+10% Y/Y) and EBITDA growing to
$41MM '25 and
$60MM in '26 (preliminary estimates, could be higher depending on ignite results).
At a sub
$300MM market cap it trades below cash, book and sales, despite immense GROWTH in business, especially as AI scales.
Stockholders equity alone is sitting at
$5/share.
We have seen recent hype in the healthcare sector amongst names like
$OSCR, but this one seems to be hidden still given its lower profile business.
On a technical basis the chart looks bottomed finally, with a strong daily and weekly base formed.
Wells Fargo gave it a
$10 price target couple weeks ago and I fully agree.
Extremely asymmetric setup, alerted in our free trading group at
$3.72.
Join for updates, trade alerts and more: http://AtaraxiaTrading.com
